Rise and shine, everyone, another busy day is on the way. We can tell because our short person is hovering once again over a laptop and our official mascot is running about the grounds in search of vermin. As for us, we would like to take a moment to note this marks 14 years since Pharmalot debuted and we want to thank the many readers who have made this such a rewarding and interesting effort. We are raising a cup of stimulation in your honor. Meanwhile, here are some tidbits. Have a great day, stay in touch and stay safe — wear a mask. …

Eli Lilly (LLY) says its monoclonal antibody prevented Covid-19 infections in nursing home residents and staff in a clinical trial, the first time such a treatment has been shown to prevent infection, STAT tells us. Lilly released the results in a press release, although it said that it would publish the data in a research paper as quickly as possible. In November, the antibody was authorized for emergency use by the Food and Drug Administration in treating Covid patients who are at risk of more severe disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.


Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]